This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simmon, K. E.
Right arrow Articles by Petti, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simmon, K. E.
Right arrow Articles by Petti, C. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2007, p. 1978-1980, Vol. 45, No. 6
0095-1137/07/$08.00+0     doi:10.1128/JCM.00563-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Identification of an Emerging Pathogen, Mycobacterium massiliense, by rpoB Sequencing of Clinical Isolates Collected in the United States{triangledown}

Keith E. Simmon,1 June I. Pounder,1 John N. Greene,2 Frank Walsh,3 Clint M. Anderson,4 Samuel Cohen,4 and Cathy A. Petti1,4,5*

Associated Regional and University Pathologists (ARUP) Institute for Clinical and Experimental Pathology, Salt Lake City, Utah,1 H. Lee Moffitt Cancer and Research Institute, Tampa, Florida,2 Department of Medicine, University of South Florida College of Medicine, Tampa, Florida,3 ARUP Laboratories, Salt Lake City, Utah,4 Departments of Medicine and Pathology, University of Utah School of Medicine, Salt Lake City, Utah5

Received 13 March 2007/ Accepted 26 March 2007


arrow
ABSTRACT
 
Mycobacterium massiliense is a rapidly growing mycobacterium that is indistinguishable from Mycobacterium chelonae/M. abscessus by partial 16S rRNA gene sequencing. We sequenced rpoB, sodA, and hsp65 genes from isolates previously identified as being M. chelonae/M. abscessus and identified M. massiliense from isolates from two patients with invasive disease representing the first reported cases in the United States.


arrow
TEXT
 
Rapidly growing mycobacterium infections are increasing in the United States (7) and are difficult to speciate by conventional methods. Partial 16S rRNA gene sequencing is the most widely used method for the identification of nontuberculous mycobacteria (6, 8, 12), but this gene target is often limited by the lack of sequence divergence among closely related Mycobacterium species (15). Mycobacterium chelonae and M. abscessus are two species that share the same 16S rRNA gene sequence, and since distinguishing these two species is clinically relevant, assays targeting base pair differences within the 16S-23S rRNA internal transcribed spacer (ITS) region have been developed (5). The ITS assay has proven to be valuable but cannot differentiate M. abscessus from M. massiliense and M. bolletii, two new species of mycobacteria that share the same 16S rRNA gene sequence with M. chelonae/M. abscessus (1, 4). Although M. massiliense and M. bolletii have not been described in the United States, these two species may have been misclassified by previous assays and may remain undetected as emerging pathogens.

We sequenced portions of the rpoB, sodA, and hsp65 genes to gain a better understanding of the frequency of detection of M. massiliense or M. bolletii among clinical isolates identified as being M. chelonae/M. abscessus by 16S and ITS assays. From this analysis, we found four isolates from two patients with identifications consistent with the novel species M. massiliense and report their clinical case histories. To our knowledge, these are the first reported cases of invasive infections from M. massiliense in the United States.

Case reports. (i) Patient 1. A 43-year-old female from Nevada with multiple sclerosis and pacemaker placement 11 months previously presented with pacemaker pocket infection. An erythematous "lump" developed at her pacemaker site that required local incision and drainage (no culture). She was treated empirically with vancomycin but developed fever and increasing pain at the site. Intraoperative cultures from surgical debridement grew colonies of acid-fast bacilli, which were identified as being M. abscessus. She remained on vancomycin. The fever persisted, and 2 weeks later, all components of the pacemaker were removed surgically, with intraoperative cultures again being positive for M. abscessus. The isolate was susceptible only to clarithromycin (MIC < 0.12 µg/ml) and amikacin (MIC < 16 µg/ml). She was discharged and received 6 months of clarithromycin treatment.

(ii) Patient 2. A 29-year-old female from Florida with chronic myelogenous leukemia received an allogeneic hematopoietic stem cell transplant that was complicated by chronic graft-versus-host disease. Five months following the hematopoietic stem cell transplant, she developed fever and cough. Cultures from bronchoalveolar lavage and multiple blood cultures recovered rapidly growing mycobacteria identified as being M. abscessus. The isolate was susceptible to linezolid (MIC < 8 mg/ml), clarithromycin (MIC < 0.12 µg/ml), and amikacin (MIC < 16 µg/ml). She received 6 weeks of treatment with intravenous tigecycline, oral moxifloxacin, and oral azithromycin.

Over a 7-month period, 63 clinical isolates, representing 58 patients, that were previously identified as harboring M. chelonae (n = 8) and M. abscessus (n = 55) by 16S and ITS sequence analyses (5) were retrieved retrospectively. DNA extractions, PCR, and sequencing reactions were performed as previously described (13) with amplification and sequencing primers targeting the rpoB (2), sodA (3), and hsp65 (14) genes. Neighbor-joining trees were constructed by using MEGA v3.1 (9). Isolates were identified by using the rpoB sequence criteria described previously by Adekambi et al. (2). Susceptibility testing was performed by broth microdilution according to CLSI (formerly NCCLS) standard M24-A (11). Doxycycline susceptibility testing was performed by Etest (AB Biodisk, Solna, Sweden).

A comparison of rpoB, sodA, and hsp65 sequences is shown in Table 1. Four isolates identified as being M. abscessus by ITS assay were identified as being M. massiliense by rpoB sequencing (Fig. 1). The rpoB sequencing results agreed with results for the ITS assay for the remaining 59 isolates. With sodA sequencing, only M. chelonae was differentiated from M. massiliense and M. abscessus (FigureGo). A total of 11 isolates had 100% identity with the previously published sodA sequence for M. massiliense. However, the rpoB sequence identified these 11 isolates as being M. massiliense (n = 4) or M. abscessus (n = 7). A comparison of the hsp65 sequences showed results that were similar to those of sodA comparisons. The 11 isolates that shared hsp65 identity with M. massiliense correlated with the 11 isolates that shared 100% sodA identity with M. massiliense. No isolates were identified as being M. bolletii. Susceptibility patterns for all 63 isolates are shown in Table 2. All M. massiliense isolates were resistant to doxycycline.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Comparison of gene sequences from clinical isolates and reference strains of M. abscessus, M. chelonae, and M. massiliense


Figure 1
View larger version (10K):
[in this window]
[in a new window]

  		FIG. 1. Phylogenetic trees of rpoB (A) and sodA (B) gene sequences. Bootstrapping values over 70% are recorded at the tree nodes. Mycobacterium leprae was used as an outgroup. Study isolates are designated AP001 to AP063. Isolates identified as being M. massiliense by rpoB sequencing are in boldface type. Isolates AP002 and AP008 represent patient 1, and isolates AP025 and AP038 represent patient 2. aIncludes isolates AP001, AP004 to AP007, AP009 to AP011, AP013 to AP015, AP017, AP020, AP021, AP023, AP024, AP026 to AP030, AP032 to AP036, AP039, AP041 to AP052, and AP056 to AP063. bIncludes isolates AP004 to AP007, AP009 to AP011, AP013 to AP015, AP017, AP020, AP021, AP023, AP024, AP026 to AP028, AP030, AP032 to AP036, AP039, AP041, AP042, AP044 to AP052, AP056, AP059, and AP061 to AP063. cIncludes isolates AP001, AP002, AP003, AP008, AP025, AP029, AP038, AP043, AP057, AP058, and AP060. dPublished sodA sequences for M. massiliense (GenBank accession number AY593975) and M. abscessus (accession number AY458102) differed by only 2 bp.


View this table:
[in this window]
[in a new window]

  		TABLE 2. Antimicrobial susceptibilities of isolates by broth microdilution method

With rpoB sequencing, 51 isolates originally identified as M. abscessus isolates by ITS assay were confirmed to be M. abscessus isolates, with 4 isolates recharacterized as harboring M. massiliense. To our knowledge, this is the first report to describe the isolation and identification of M. massiliense isolates collected in the United States associated with invasive infections, and it suggests that M. massiliense may be more commonly encountered but may be potentially misclassified as M. abscessus.

Unlike partial 16S rRNA gene sequencing, where interspecies similarity is high, with ≤0.4% sequence differences, the rpoB gene sequence is more variable, with 2 to 3% sequence differences correctly classifying most nontuberculous mycobacteria (9). In this study, we found partial rpoB gene sequencing to be a more discriminating gene target than sodA and hsp65 for M. massiliense, a unique observation that conflicts with data from previous reports (4, 10). Additionally, other investigators previously proposed that susceptibility to doxycycline may serve as a surrogate marker to differentiate M. abscessus from M. massiliense (4), but we could not confirm this finding.

Distinguishing M. chelonae from M. abscessus is clinically important because of their unique susceptibility patterns and disease manifestations. Our understanding of M. massiliense representing a distinct clinical and taxonomical entity from M. abscessus is still evolving. For our two patients, no histories of unusual exposure to animals or environmental sources were present, and their clinical presentations and susceptibility patterns were similar to those of infections caused by M. abscessus.

Overall, rpoB gene sequencing is emerging as the preferred tool to identify mycobacteria taxa (1-4) and enabled us to identify M. massiliense from two patients with invasive infection. Although the clinical significance of routinely identifying certain mycobacteria remains unclear, the 16S rRNA gene and ITS regions are often inadequate to completely capture the microbial diversity of mycobacteria, and alternative gene targets such as the rpoB gene should be considered to recognize emerging mycobacterial pathogens with the potential for invasive disease.


arrow
ACKNOWLEDGMENTS
 
This work was supported by the Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology, an enterprise of the University of Utah and its Department of Pathology.

We have no conflict of interest regarding the software, products, or concepts used in this study.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: ARUP Laboratories, 500 Chipeta Way, Salt Lake City, UT 84108. Phone: (801) 583-2787. Fax: (801) 584-5207. E-mail: cathy.petti{at}aruplab.com Back

{triangledown} Published ahead of print on 4 April 2007. Back


arrow
REFERENCES
 
    1
  1. Adekambi, T., P. Berger, D. Raoult, and M. Drancourt. 2006. rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov. Int. J. Syst. Evol. Microbiol. 56:133-143.[Abstract/Free Full Text]
    2. 2
  2. Adekambi, T., P. Colson, and M. Drancourt. 2003. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. J. Clin. Microbiol. 41:5699-5708.[Abstract/Free Full Text]
    3. 3
  3. Adekambi, T., and M. Drancourt. 2004. Dissection of phylogenetic relationships among 19 rapidly growing Mycobacterium species by 16S rRNA, hsp65, sodA, recA and rpoB gene sequencing. Int. J. Syst. Evol. Microbiol. 54:2095-2105.[Abstract/Free Full Text]
    4. 4
  4. Adékambi, T., M. Reynaud-Gaubert, G. Greub, M.-J. Gevaudan, B. La Scola, D. Raoult, and M. Drancourt. 2004. Amoebal coculture of "Mycobacterium massiliense" sp. nov. from the sputum of a patient with hemoptoic pneumonia. J. Clin. Microbiol. 42:5493-5501.[Abstract/Free Full Text]
    5. 5
  5. Cloud, J. L., K. Hoggan, E. Belousov, S. Cohen, B. Brown-Elliot, L. Mann, R. Wilson, W. Aldous, R. J. Wallace, and G. L. Woods. 2005. Use of the MGB Eclipse system and SmartCycler PCR for differentiation of Mycobacterium chelonae and M. abscessus. J. Clin. Microbiol. 43:4205-4207.[Abstract/Free Full Text]
    6. 6
  6. Cloud, J. L., H. Neal, R. Rosenberry, C. Y. Turenne, M. Jama, D. R. Hillyard, and K. C. Carroll. 2002. Identification of Mycobacterium spp. by using a commercial 16S ribosomal DNA sequencing kit and additional sequencing libraries. J. Clin. Microbiol. 40:400-406.[Abstract/Free Full Text]
    7. 7
  7. De Groote, M. A., and G. Huitt. 2006. Infections due to rapidly growing mycobacteria. Clin. Infect. Dis. 42:1756-1763.[CrossRef][Medline]
    8. 8
  8. Hall, L., K. A. Doerr, S. L. Wohlfiel, and G. D. Roberts. 2003. Evaluation of the MicroSeq system for identification of mycobacteria by 16S ribosomal DNA sequencing and its integration into a routine clinical mycobacteriology laboratory. J. Clin. Microbiol. 41:1447-1453.[Abstract/Free Full Text]
    9. 9
  9. Kumar, S., K. Tamura, and M. Nei. 2004. MEGA 3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5:150-163.[Abstract/Free Full Text]
    10. 10
  10. McNabb, A., K. Adie, M. Rodrigues, W. A. Black, and J. Isaac-Renton. 2006. Direct identification of mycobacteria in primary liquid detection media by partial sequencing of the 65-kilodalton heat shock protein gene. J. Clin. Microbiol. 44:60-66.[Abstract/Free Full Text]
    11. 11
  11. NCCLS. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes: approved standard. NCCLS document M24-A. NCCLS, Wayne, PA.
    12. 12
  12. Patel, J. B., D. G. B. Leonard, X. Pan, J. M. Musser, R. E. Berman, and I. Nachamkin. 2000. Sequence-based identification of Mycobacterium species using the MicroSeq 500 16S rDNA bacterial identification system. J. Clin. Microbiol. 38:246-251.[Abstract/Free Full Text]
    13. 13
  13. Simmon, K. E., A. C. Croft, and C. A. Petti. 2006. Application of SmartGene IDNS software for partial 16S rRNA gene sequences for a diverse group of bacteria in a clinical laboratory. J. Clin. Microbiol. 44:4400-4406.[Abstract/Free Full Text]
    14. 14
  14. Telenti, A., F. Marchesi, M. Balz, F. Bally, E. C. Bottger, and T. Bodmer. 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J. Clin. Microbiol. 31:175-178.[Abstract/Free Full Text]
    15. 15
  15. Tortoli, E. 2003. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin. Microbiol. Rev. 16:319-354.[Abstract/Free Full Text]

Journal of Clinical Microbiology, June 2007, p. 1978-1980, Vol. 45, No. 6
0095-1137/07/$08.00+0     doi:10.1128/JCM.00563-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Duarte, R. S., Lourenco, M. C. S., Fonseca, L. d. S., Leao, S. C., Amorim, E. d. L. T., Rocha, I. L. L., Coelho, F. S., Viana-Niero, C., Gomes, K. M., da Silva, M. G., de Oliveira Lorena, N. S., Pitombo, M. B., Ferreira, R. M. C., de Oliveira Garcia, M. H., de Oliveira, G. P., Lupi, O., Vilaca, B. R., Serradas, L. R., Chebabo, A., Marques, E. A., Teixeira, L. M., Dalcolmo, M., Senna, S. G., Sampaio, J. L. M. (2009). Epidemic of Postsurgical Infections Caused by Mycobacterium massiliense. J. Clin. Microbiol. 47: 2149-2155 [Abstract] [Full Text]  
  • Zelazny, A. M., Root, J. M., Shea, Y. R., Colombo, R. E., Shamputa, I. C., Stock, F., Conlan, S., McNulty, S., Brown-Elliott, B. A., Wallace, R. J. Jr., Olivier, K. N., Holland, S. M., Sampaio, E. P. (2009). Cohort Study of Molecular Identification and Typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii. J. Clin. Microbiol. 47: 1985-1995 [Abstract] [Full Text]  
  • Simmon, K. E., Low, Y. Y., Brown-Elliott, B. A., Wallace, R. J. Jr, Petti, C. A. (2009). Phylogenetic analysis of Mycobacterium aurum and Mycobacterium neoaurum with redescription of M. aurum culture collection strains. Int. J. Syst. Evol. Microbiol. 59: 1371-1375 [Abstract] [Full Text]  
  • Marchandin, H., Battistella, P., Calvet, B., Darbas, H., Frapier, J.-M., Jean-Pierre, H., Parer, S., Jumas-Bilak, E., Van de Perre, P., Godreuil, S. (2009). Pacemaker surgical site infection caused by Mycobacterium goodii. J Med Microbiol 58: 517-520 [Abstract] [Full Text]  
  • Medjahed, H., Reyrat, J.-M. (2009). Construction of Mycobacterium abscessus Defined Glycopeptidolipid Mutants: Comparison of Genetic Tools. Appl. Environ. Microbiol. 75: 1331-1338 [Abstract] [Full Text]  
  • Kim, H.-Y., Kook, Y., Yun, Y.-J., Park, C. G., Lee, N. Y., Shim, T. S., Kim, B.-J., Kook, Y.-H. (2008). Proportions of Mycobacterium massiliense and Mycobacterium bolletii Strains among Korean Mycobacterium chelonae-Mycobacterium abscessus Group Isolates. J. Clin. Microbiol. 46: 3384-3390 [Abstract] [Full Text]  
  • Sampaio, E. P., Elloumi, H. Z., Zelazny, A., Ding, L., Paulson, M. L., Sher, A., Bafica, A. L., Shea, Y. R., Holland, S. M. (2008). Mycobacterium abscessus and M. avium Trigger Toll-Like Receptor 2 and Distinct Cytokine Response in Human Cells. Am. J. Respir. Cell Mol. Bio. 39: 431-439 [Abstract] [Full Text]  
  • Viana-Niero, C., Lima, K. V. B., Lopes, M. L., da Silva Rabello, M. C., Marsola, L. R., Brilhante, V. C. R., Durham, A. M., Leao, S. C. (2008). Molecular Characterization of Mycobacterium massiliense and Mycobacterium bolletii in Isolates Collected from Outbreaks of Infections after Laparoscopic Surgeries and Cosmetic Procedures. J. Clin. Microbiol. 46: 850-855 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simmon, K. E.
Right arrow Articles by Petti, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simmon, K. E.
Right arrow Articles by Petti, C. A.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»